Kenney L, Hughes M
Cancers (Basel). 2025; 17(3).
PMID: 39941746
PMC: 11816225.
DOI: 10.3390/cancers17030377.
Li L, Chen Z, Zhu D, Lv Q, Zhang T, Lai J
Int J Surg Case Rep. 2025; 127:110963.
PMID: 39889652
PMC: 11834123.
DOI: 10.1016/j.ijscr.2025.110963.
Stefano E, Castro F, Ciccarese A, Muscella A, Marsigliante S, Benedetti M
Int J Mol Sci. 2024; 25(16).
PMID: 39201255
PMC: 11354135.
DOI: 10.3390/ijms25168568.
Baudin E, Capdevila J, Horsch D, Singh S, Caplin M, Wolin E
Endocr Relat Cancer. 2024; 31(9).
PMID: 38913539
PMC: 11301421.
DOI: 10.1530/ERC-23-0337.
Chen G, Liu L, Tan C, Tan Q, Chen Y, An X
Cancer Med. 2024; 13(7):e7114.
PMID: 38553949
PMC: 10980930.
DOI: 10.1002/cam4.7114.
Neuroendocrine tumor of the appendix masquerading as acute appendicitis with a mucocele on CT scan: a rare finding.
Al-Darwish A, Alsubaie W, AlShammari W, AlaSheikh M, Alrashed M
Surg Case Rep. 2024; 10(1):65.
PMID: 38499895
PMC: 10948727.
DOI: 10.1186/s40792-024-01870-5.
Does Telotristat Have a Role in Preventing Carcinoid Heart Disease?.
Herrera-Martinez A, Fuentes-Fayos A, Sanchez-Sanchez R, Montero A, Sarmento-Cabral A, Galvez-Moreno M
Int J Mol Sci. 2024; 25(4).
PMID: 38396713
PMC: 10888480.
DOI: 10.3390/ijms25042036.
When Should Lymphadenectomy Be Performed in Non-Metastatic Pancreatic Neuroendocrine Tumors? A Population-Based Analysis of the German Clinical Cancer Registry Group.
Abdalla T, Bolm L, Klinkhammer-Schalke M, Zeissig S, Kleihues van Tol K, Bronsert P
Cancers (Basel). 2024; 16(2).
PMID: 38275882
PMC: 10814740.
DOI: 10.3390/cancers16020440.
Radiation Exposure from GEP NET Surveillance.
Iannuzzi J, Yeo C, Parkins V, Ruether D, Stewart E, Chan D
Cancers (Basel). 2024; 16(2).
PMID: 38275868
PMC: 10814752.
DOI: 10.3390/cancers16020427.
Endoscopic Management of Gastro-Entero-Pancreatic Neuroendocrine Tumours: An Overview of Proposed Resection and Ablation Techniques.
Chacchi-Cahuin R, Despott E, Lazaridis N, Rimondi A, Fusai G, Mandair D
Cancers (Basel). 2024; 16(2).
PMID: 38254841
PMC: 10814323.
DOI: 10.3390/cancers16020352.
Emerging Precision Medicine Approaches for Lung Neuroendocrine Tumors.
Mulvey C
Cancers (Basel). 2023; 15(23).
PMID: 38067279
PMC: 10705103.
DOI: 10.3390/cancers15235575.
Duodenal neuroendocrine tumors: Short-term outcomes of endoscopic submucosal dissection performed in the Western setting.
Gupta S, Kumar P, Chacchi R, Murino A, Despott E, Lemmers A
Endosc Int Open. 2023; 11(11):E1099-E1107.
PMID: 38026782
PMC: 10681807.
DOI: 10.1055/a-2181-0320.
Correlation between clinicopathological characteristics and the clinical prognosis of patients with gastroenteropancreatic neuroendocrine tumors.
Fan D, Li X, Yu Y, Wang X, Fang J, Huang C
Mol Clin Oncol. 2023; 19(5):85.
PMID: 37809346
PMC: 10557094.
DOI: 10.3892/mco.2023.2681.
A radiomics-based interpretable model to predict the pathological grade of pancreatic neuroendocrine tumors.
Ye J, Fang P, Peng Z, Huang X, Xie J, Yin X
Eur Radiol. 2023; 34(3):1994-2005.
PMID: 37658884
PMC: 10873440.
DOI: 10.1007/s00330-023-10186-1.
Role of Advanced Gastrointestinal Endoscopy in the Comprehensive Management of Neuroendocrine Neoplasms.
Gopakumar H, Jahagirdar V, Koyi J, Dahiya D, Goyal H, Sharma N
Cancers (Basel). 2023; 15(16).
PMID: 37627203
PMC: 10453187.
DOI: 10.3390/cancers15164175.
Observational study of surgical resection in small non-functional pancreatic neuroendocrine tumors: AS SEER-based study.
Lin J, Huang H
Sci Rep. 2023; 13(1):12824.
PMID: 37550460
PMC: 10406806.
DOI: 10.1038/s41598-023-39980-z.
Recombinant α-Microglobulin (rA1M) Protects against Hematopoietic and Renal Toxicity, Alone and in Combination with Amino Acids, in a Lu-DOTATATE Mouse Radiation Model.
Alattar A, Kristiansson A, Karlsson H, Vallius S, Ahlstedt J, Forssell-Aronsson E
Biomolecules. 2023; 13(6).
PMID: 37371508
PMC: 10296637.
DOI: 10.3390/biom13060928.
Utility of histopathological revision in the management of gastro-entero-pancreatic neuroendocrine neoplasia.
Marasco M, Magi L, Rogges E, DellUnto E, Rinzivillo M, Pilozzi E
Endocrine. 2023; 82(2):435-441.
PMID: 37338723
PMC: 10543798.
DOI: 10.1007/s12020-023-03418-3.
Surgical Management of Pancreatic Neuroendocrine Tumors.
Sulciner M, Clancy T
Cancers (Basel). 2023; 15(7).
PMID: 37046665
PMC: 10093271.
DOI: 10.3390/cancers15072006.
Clinical Prediction Models for Recurrence in Patients with Resectable Grade 1 and 2 Sporadic Non-Functional Pancreatic Neuroendocrine Tumors: A Systematic Review.
Chen J, Heidsma C, Engelsman A, Kabaktepe E, van Dieren S, Falconi M
Cancers (Basel). 2023; 15(5).
PMID: 36900316
PMC: 10001130.
DOI: 10.3390/cancers15051525.
